{
    "label": "Age of patient?",
    "node_type": "fieldset",
    "children": [
        {
            "label": "For patients 18 years or older",
            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "Is this request for initiation or continuation of therapy with Wegovy™ (semaglutide)?",
                    "node_type": "fieldset",
                    "children": [
                        {
                            "label": "Start of therapy for weight management",
                            "outcome": "Initiation of Wegovy™ (semaglutide) may be approved for up to 16 weeks when all of the following criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Member meets one of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Documented initial baseline body mass index (BMI) ≥ 30 kg/m2",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Meets body mass index (BMI) and comorbidity requirements:",
                                            "all_required": true,
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "children": [
                
                                                {
                                                    "label": "A documented body mass index (BMI) ≥ 27 kg/m^2",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                },
                                                {
                                                    "label": "Document all the weight-related comorbid conditions the patient has (at least one required):",
                                                    "node_type": "checkbox",
                                                    "node_value": false,
                                                    "children": [
                                                        {
                                                            "label": "Established cardiovascular disease or stroke",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "diagnosis": true
                                                        },
                                                        {
                                                            "label": "Hypertension",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "diagnosis": true
                                                        },
                                                        {
                                                            "label": "Type 2 diabetes (DM)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "diagnosis": true
                                                        },
                                                        {
                                                            "label": "Chronic kidney disease (CKD)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "diagnosis": true
                                                        },
                                                        {
                                                            "label": "Congenital heart disease (CHD)",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "diagnosis": true
                                                        },
                                                        {
                                                            "label": "Obstructive sleep apnea",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "diagnosis": true
                                                        },
                                                        {
                                                            "label": "Polycystic ovarian syndrome",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "diagnosis": true
                                                        },
                                                        {
                                                            "label": "Dyslipidemia",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "diagnosis": true
                                                        },
                                                        {
                                                            "label": "Non-alcoholic fatty liver disease",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "diagnosis": true
                                                        },
                                                        {
                                                            "label": "Idiopathic intracranial hypertension",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "diagnosis": true
                                                        },
                                                        {
                                                            "label": "Osteoarthritis in weight-bearing joints",
                                                            "node_type": "checkbox",
                                                            "node_value": false,
                                                            "diagnosis": true
                                                        }
                                                    ]
                                                }
                                            ]
                                        }
                                    ]
                                },
                                {
                                    "label": "Document Wegovy is not prescribed concurrently with other semaglutide-containing products or any other GLP-1 receptor agonist(s)",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document that member is actively enrolled in a weight-loss program that involves a reduced calorie diet and increased physical activity adjunct to therapy",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Dose does not exceed the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Week 1 through 4: 0.25 mg once weekly",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Week 5 through 8: 0.5 mg once weekly",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Week 9 through 12: 1 mg once weekly",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Week 13 through 16: 1.7 mg once weekly",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "label": "Continuation of therapy",
                            "outcome": "Continuation of Wegovy™ (semaglutide) therapy may be approved for up to an additional 365 days (1 year) when all of the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Member meets one of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Document patient is currently receiving medication via Centene benefit or member has previously met initial approval criteria",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Document member is currently receiving medication and is enrolled in a state and product with continuity of care regulations",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "Member is responding positively to therapy as evidenced by one of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "If this is the first renewal request, document that member has lost ≥ 5% of baseline body weight (adults)",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "If this is a second or subsequent renewal request, document member has lost weight and/or maintained weight loss on therapy",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "Document Wegovy is not prescribed concurrently with other semaglutide-containing products or any other GLP-1 receptor agonist(s)",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document that member is actively enrolled in a weight loss program that involves a reduced calorie diet and increased physical activity adjunct to therapy",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Request meets both of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "all_required": true,
                                    "children": [
                                        {
                                            "label": "Dose does not exceed 2.4 mg once weekly",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "After the initial dose escalation period, one of the following:",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "children": [
                                                {
                                                    "label": "Maintenance dose is 2.4 mg",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                },
                                                {
                                                    "label": "A temporary dose reduction to 1.7 mg is needed for a maximum of 4 weeks",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        },
        {
            "label": "For patients aged 12 to 17 years",
            "outcome": "Authorization for Wegovy™ (semaglutide), may be approved when all of the criteria are met",
            "node_type": "radio",
            "node_value": false,
            "children": [
                {
                    "label": "Is this request for initiation or continuation of therapy with Wegovy™ (semaglutide)?",
                    "node_type": "fieldset",
                    "children": [
                        {
                            "label": "Start of therapy for weight management",
                            "outcome": "Initiation of Wegovy™ (semaglutide) may be approved for up to 16 weeks when all of the following criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Documented BMI ≥ 95th percentile standardized for age and sex",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Age ≥ 12 years",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document Wegovy is not prescribed concurrently with other semaglutide-containing products or any other GLP-1 receptor agonist(s)",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document that member is actively enrolled in a weight loss program that involves a reduced calorie diet and increased physical activity adjunct to therapy",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Dose does not exceed the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Week 1 through 4: 0.25 mg once weekly",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Week 5 through 8: 0.5 mg once weekly",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Week 9 through 12: 1 mg once weekly",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Week 13 through 16: 1.7 mg once weekly",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                }
                            ]
                        },
                        {
                            "label": "Continuation of therapy",
                            "outcome": "Continuation of Wegovy™ (semaglutide) therapy may be approved for up to an additional 365 days (1 year) when all of the criteria are met",
                            "node_type": "radio",
                            "node_value": false,
                            "children": [
                                {
                                    "label": "Member meets one of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "Document currently receiving medication via Centene benefit or member has previously met initial approval criteria",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "Document Member is currently receiving medication and is enrolled in a state and product with continuity of care regulations",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "Member is responding positively to therapy as evidenced by one of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "children": [
                                        {
                                            "label": "If this is the first renewal request, document member has lost ≥ 5% of baseline BMI (pediatrics)",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "If this is a second or subsequent renewal request, document member has lost weight and/or maintained weight loss on therapy",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        }
                                    ]
                                },
                                {
                                    "label": "Document Wegovy is not prescribed concurrently with other semaglutide-containing products or any other GLP-1 receptor agonist(s)",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Document that member is actively enrolled in a weight loss program that involves a reduced calorie diet and increased physical activity adjunct to therapy",
                                    "node_type": "checkbox",
                                    "node_value": false
                                },
                                {
                                    "label": "Request meets both of the following:",
                                    "node_type": "checkbox",
                                    "node_value": false,
                                    "all_required": true,
                                    "children": [
                                        {
                                            "label": "Dose does not exceed 2.4 mg once weekly",
                                            "node_type": "checkbox",
                                            "node_value": false
                                        },
                                        {
                                            "label": "After the initial dose escalation period, one of the following:",
                                            "node_type": "checkbox",
                                            "node_value": false,
                                            "children": [
                                                {
                                                    "label": "Maintenance dose is 2.4 mg",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                },
                                                {
                                                    "label": "Maintenance dose is 1.7 mg",
                                                    "node_type": "checkbox",
                                                    "node_value": false
                                                }
                                            ]
                                        }
                                    ]
                                }
                            ]
                        }
                    ]
                }
            ]
        }
    ]
}